Skip to main content

Will Suhikian

Analyst

Leerink Partners

Equibles does not estimate personal net worth.

About Will Suhikian

Will Suhikian is recorded as Analyst at Leerink Partners. Will Suhikian has spoken on 2 earnings calls across 2 companies, most recently for Travere Therapeutics, Inc. on May 4, 2026. Those appearances were for Travere Therapeutics, Inc. (TVTX) and Ultragenyx Pharmaceutical Inc. (RARE). The companies whose calls Will Suhikian spoke on are classified in the Healthcare sector.

Will Suhikian on recent calls

“The one for us on FSGS, you guys have messaged several times that the launch is expected to progress at a faster rate than IJ nephropathy. Could you please characterize what you are seeing at this early stage and how it compares to the original IGAN rollout a few years ago?”
Analyst — Leerink Partners, Travere Therapeutics, Inc. Q1 FY2026 Earnings Call ·
“I have one on Angelman and then a quick follow-up. So, for GTX102, the company has consistently stated that it is the most potent ASO in development. We're just wondering, is this claim based on the ATS knockdown or perhaps its mRNA or protein increases preclinically?”
Analyst — Leerink Partners, Ultragenyx Pharmaceutical Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Leerink Partners

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity